Comparative Pharmacology
Head-to-head clinical analysis: MIDAZOLAM HYDROCHLORIDE AUTOINJECTOR versus NAYZILAM.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MIDAZOLAM HYDROCHLORIDE AUTOINJECTOR versus NAYZILAM.
MIDAZOLAM HYDROCHLORIDE (AUTOINJECTOR) vs NAYZILAM
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Midazolam is a short-acting benzodiazepine that potentiates GABA-A receptor activity by binding to the benzodiazepine site, enhancing chloride ion conductance and neuronal hyperpolarization, leading to anxiolytic, sedative, amnestic, anticonvulsant, and muscle relaxant effects.
Nayzilam (midazolam) is a benzodiazepine that enhances the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABA-A receptor, resulting in increased chloride ion conductance, neuronal hyperpolarization, and inhibition of neuronal activity.
10 mg intramuscularly once via autoinjector for acute seizure control.
5 mg intranasally as a single dose; may repeat once after 10 minutes if needed. Maximum 10 mg per episode.
None Documented
None Documented
Terminal elimination half-life is 1.8–6.4 hours (mean ~3 hours) in healthy adults; prolonged in elderly, obese, hepatic impairment (up to 15–20 hours), and critical illness.
Terminal elimination half-life of midazolam is 1.5–2.5 hours, but for NAYZILAM (midazolam nasal spray) the effective half-life for anticonvulsant effect is approximately 2–3 hours due to prolonged absorption; clinical context: used for seizure clusters, duration of effect may persist for 4–6 hours.
Renal excretion of metabolites (glucuronide conjugates) accounts for approximately 90% of elimination; less than 1% excreted unchanged; minimal fecal excretion (< 5%).
Renal excretion as metabolites (primarily glucuronide conjugates) and unchanged drug; approximately 15% recovered in urine as unchanged midazolam, with the remainder as metabolites; <1% excreted in feces via biliary elimination.
Category D/X
Category C
Benzodiazepine
Benzodiazepine